Horizon Pharma plc Intellectual Property Contracts & Agreements
21 Contracts & Agreements
- License Agreements (21 contracts)
- Amendment No. 10 to the License Agreement, dated May 22, 2023, by and among F. Hoffmann-La Roche Ltd, Hoffman-La Roche Inc. and Horizon Therapeutics Ireland DAC (as successor in... (Filed With SEC on August 8, 2023)
- License Agreement, dated April 16, 1999, by and among Saul Brusilow, M.D., Brusilow Enterprises, Inc. and Horizon Therapeutics, LLC (as successor in interest to Medicis... (Filed With SEC on February 24, 2021)
- License Agreement, dated August 12, 1998, by and among Mountain View Pharmaceuticals, Inc., Duke University and Horizon Therapeutics Ireland DAC (as successor in interest to... (Filed With SEC on February 24, 2021)
- License Agreement, effective as of June 15, 2011, by and among F. Hoffmann-La Roche Ltd, Hoffman-La Roche Inc. and Horizon Therapeutics Ireland DAC (as successor in interest to... (Filed With SEC on February 26, 2020)
- License Agreement, effective as of June 15, 2011, by and among F. Hoffmann-La Roche Ltd, Hoffman-La Roche Inc. and River Vision Development Corp, as amended through Amendment No.... (Filed With SEC on May 8, 2019)
- Exclusive License Agreement, dated December 5, 2012, by and between Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and River Vision Development Corp (Filed With SEC on May 8, 2019)
- Amendment No. 1 to Amended and Restated License Agreement, dated September 11, 2018, by and between Horizon Orphan LLC and The Regents of the University of California (Filed With SEC on November 7, 2018)
- AMENDED AND RESTATED LICENSE AGREEMENT BETWEEN HORIZON ORPHANLLC AND THEREGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NOS. SD2006-092, SD2017-110, SD2017-113 AND SD2017-236... (Filed With SEC on August 7, 2017)
- SECOND AMENDMENT [Drafted as AMENDED AND RESTATED] LICENSE AGREEMENT BETWEEN RAPTOR THERAPEUTICS, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. SD2006-092... (Filed With SEC on November 7, 2016)
- LICENSE AGREEMENT FOR INTERFERON GAMMA (Filed With SEC on February 27, 2015)
- AMENDMENT NO. ONE TO LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- AMENDMENT NO. TWO TO LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- AMENDMENT NO. THREE TO LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- AMENDMENT No. 6 to the License Agreement for Interferon Gamma (Filed With SEC on February 27, 2015)
- SEVENTH AMENDMENT TO LICENSE AGREEMENT FOR INTERFERON GAMMA (Filed With SEC on February 27, 2015)
- LICENSE AGREEMENT By and between AstraZeneca AB and Horizon Pharma USA, Inc. Dated as of November 22, 2013 (Filed With SEC on March 13, 2014)
- Transfer, License and Supply Agreement between Merck Pharma GmbH Alsfelder Straße 17, 64289 Darmstadt, Germany (Merck), and Nitec Pharma AG Röschenzerstr. 9, 4153 Reinach,... (Filed With SEC on June 7, 2011)
- Transfer, License and Supply Agreement between Merck Pharma GmbH Alsfelder Straße 17, 64289 Darmstadt, Germany (Merck), and Nitec Pharma AG Röschenzerstr. 9, 4153 Reinach,... (Filed With SEC on October 21, 2010)
- Transfer, License and Supply Agreement between Merck GesmbH Zimbagasse 5 A-1147 Vienna, Austria (Merck), and Nitec Pharma AG Kagenstr 17, 4153 Reinach, Switzerland (Nitec AG) and... (Filed With SEC on October 21, 2010)
- Transfer, License and Supply Agreement between Merck Pharma GmbH Alsfelder Straße 17, 64289 Darmstadt, Germany (Merck), and Nitec Pharma AG Röschenzerstr. 9, 4153 Reinach,... (Filed With SEC on August 3, 2010)
- Transfer, License and Supply Agreement between Merck GesmbH Zimbagasse 5 A-1147 Vienna, Austria (Merck), and NitecPharma AG Kagenstr 17, 4153 Reinach, Switzerland (Nitec AG) and... (Filed With SEC on August 3, 2010)
